✦ LIBER ✦

An FDA perspective on the nonclinical use of the X-Omics technologies and the safety of new drugs

✍ Scribed by Abigail Jacobs

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The US FDA requires a “new vision of dru

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 120 KB

An Early Historical Perspective on the F

✍ Mary K. Bruch and Elaine Larson 📂 Article 📅 1989 🏛 University of Chicago Press 🌐 English ⚖ 458 KB

An Industry Perspective on the Timely In

📂 Article 📅 2003 🏛 American Society of Naval Engineers 🌐 English ⚖ 59 KB

Evaluating the Early Impact of the Food

✍ Myers, E.M.; Crane, A.K.; Geller, E.J.; Robinson, B.L.; Matthews, C.A. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 141 KB

The use of manufacturing technologies–an

✍ Das, Ajay; Nair, Anand 📂 Article 📅 2009 🏛 Taylor and Francis Group 🌐 English ⚖ 329 KB

FDA and Drug Safety: New Tufts Study Cha

✍ Rochelle Lee 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB